Journal Reviews

BJUI International journal cover image.

BCG after TURBT – does timing matter?

2 March 2022 | | Urologic Oncology | #BladderCancer, #blcsm, #uroonc, BCG-unresponsive, bacille Calmette-Guérin, bladder cancer, intravesical therapy, transurethral resection of bladder tumour

Intravesical bacille Calmette–Guerin (BCG) therapy continues to be widely used for patients with intermediate / high-risk non-muscle invasive bladder cancer (NMIBC). In this article, the researchers identified the lack of sufficient evidence with regards to timing of BCG after transurethral...

The importance of second-look transurethral resection for superficial bladder cancer

1 March 2016 | | Urologic Oncology | Bladder cancer, second look, transurethral resection, treatment

This was a prospective study of 100 consecutive patients with a newly diagnosed superficial bladder tumour who underwent a second look transurethral resection of bladder tumour (TURBT) two to six weeks post initial resection. This essentially included pTa multiple and...